Key result
Dietary treatments promoting low fat, low cholesterol, and polyunsaturated diets have not abated the epidemic of coronary heart disease or changed population cholesteremia.
The editorial critiques the long-standing dietary treatment approach (low fat, low cholesterol) for coronary heart disease, noting its lack of efficacy in curbing the epidemic.
A GENERATION of research on the diet-heart question has ended in disarray. The official line since 1950 for management of the epidemic of coronary heart disease has been a dietary treatment. Foundations, scientists and the media, both lay and scientific, have promoted low fat, low cholesterol, polyunsaturated diets, and yet the epidemic continues unabated, cholesteremia in the population is unchanged, and clinicians are unconvinced of efficacy. An editorial appeared in these pages a few months ago with the plaintive title, "Needed: New therapy for hypercholesterolemia."1 Eminent cardiologists began an essay on the subject with the thoughtful title, "Prevention of Heart . . .
No takes yet. Share an insight, caveat, or question.
George V. Mann (1977) conducted an editorial in Coronary heart disease and hypercholesterolemia. Low fat, low cholesterol, polyunsaturated diets was evaluated. Dietary treatments promoting low fat, low cholesterol, and polyunsaturated diets have not abated the epidemic of coronary heart disease or changed population cholesteremia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: